Comparison of skeletal effects of ovariectomy versus chemically induced ovarian failure in mice

Journal of Bone and Mineral Research

Volumn 23, Issue 8, 2008, Pages 1296-1303

  Wright, Laura E ^a   Christian, Patricia J ^a   Rivera, Zelieann ^a   Van Alstine, William G ^b   Funk, Janet L ^a   Bouxsein, Mary L ^c   Hoyer, Patricia B ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b PURDUE UNIVERSITY   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

BMD; Menopause; Microarchitecture; Murine

Indexed keywords

4 VINYLCYCLOHEXENE DIEPOXIDE; ANDROSTENEDIONE; EPOXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; BONE DENSITY; BONE DISEASE; C57BL 6 MOUSE; COMPARATIVE STUDY; CONTROLLED STUDY; CORTICAL BONE; DIAPHYSIS; EX VIVO STUDY; FEMALE; FEMUR; MENOPAUSE; MONITORING; MOUSE; NONHUMAN; OSTEOLYSIS; OVARIECTOMY; OVARY INSUFFICIENCY; SKELETON; SPINE; STATISTICAL SIGNIFICANCE; THICKNESS; TRABECULAR BONE; VAGINA CYTOLOGY;

ANDROSTENEDIONE; ANIMALS; BODY WEIGHT; BONE AND BONES; BONE DENSITY; CYCLOHEXENES; ESTRADIOL; FEMALE; MICE; MICE, INBRED C57BL; ORGAN SIZE; OVARIAN FAILURE, PREMATURE; OVARIECTOMY; TIME FACTORS; VINYL COMPOUNDS;

EID: 47849085662     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.080309     Document Type: Article

References (45)

1. Jones E, DeCherney A 2005 The female reproductive system. In: Boron W, Boulpaep E (eds.) Medical Physiology: A Cellular and Molecular Approach. Elsevier Saunders, Philadelphia, PA, USA, pp. 1163-1165.
2. Riggs BL, Melton LJ III 1986 Involutional osteoporosis. N Engl J Med 314:1676-1686.
3. Compston JE 2001 Sex steroids and bone. Physiol Rev 81:419-447.
4. Riggs BL, Khosla S, Melton LJ III 2002 Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 23:279-302.
5. Manolagas SC, Kousteni S, Jilka RL 2002 Sex steroids and bone. Recent Prog Horm Res 57:385-409.
6. Perrien DS, Akel NS, Edwards PK, Carver AA, Bendre MS, Swain FL, Skinner RA, Hogue WR, Nicks KM, Pierson TM, Suva LJ, Gaddy D 2007 Inhibin A is an endocrine stimulator of bone mass and strength. Endocrinology 148:1654-1665.
7. Gaddy-Kurten D, Coker JK, Abe E, Jilka RL, Manolagas SC 2002 Inhibin suppresses and activin stimulates osteoblastogenesis and osteoclastogenesis in murine bone marrow cultures. Endocrinology 143:74-83.
8. Perrien DS, Achenbach SJ, Bledsoe SE, Walser B, Suva LJ, Khosla S, Gaddy D 2006 Bone turnover across the menopause transition: Correlations with inhibins and follicle-stimulating hormone. J Clin Endocrinol Metab 91:1848-1854.
9. Zhang Z, Sun L, Peng Y, Iqbal J, Zaidi S, Papachristou D, Zhou H, Sharrow A, Yaroslavskiy B, Zhu L, Zallone A, Sairam M, Kumar T, Cardosa-Landa L, Schaffler M, Moonga B, Blair H, Zaidi M 2005 The pituitary hormone, FSH, directly enhances osteoclast formation and survival. J Bone Miner Res 20:S26.
10. Ebeling PR, Atley LM, Guthrie JR, Burger HG, Dennerstein L, Hopper JL, Wark JD 1996 Bone turnover markers and bone density across the menopausal transition. J Clin Endocrinol Metab 81:3366-3371.
11. Sowers MR, Finkelstein JS, Ettinger B, Bondarenko I, Neer RM, Cauley JA, Sherman S, Greendale GA 2003 The association of endogenous hormone concentrations and bone mineral density measures in pre- and perimenopausal women of four ethnic groups: SWAN. Osteoporos Int 14:44-52.
12. Sowers MR, Greendale GA, Bondarenko I, Finkelstein JS, Cauley JA, Neer RM, Ettinger B 2003 Endogenous hormones and bone turnover markers in pre- and perimenopausal women: SWAN. Osteoporos Int 14:191-197.
13. van Weerden WM, Bierings HG, van Steenbrugge GJ, Dejong FH, Schroder FH 1992 Adrenal glands of mouse and rat do not synthesize androgens. Life Sci 50:857-861.
14. Mayer LP, Devine PJ, Dyer CA, Hoyer PB 2004 The follicle-deplete mouse ovary produces androgen. Biol Reprod 71:130-138.
15. Lohff JC, Christian PJ, Marion SL, Arrandale A, Hoyer PB 2005 Characterization of cyclicity and hormonal profile with impending ovarian failure in a novel chemical-induced mouse model of perimenopause. Comp Med 55:523-527.
16. Lohff JC, Christian PJ, Marion SL, Hoyer PB 2006 Effect of duration of dosing on onset of ovarian failure in a chemical-induced mouse model of perimenopause. Menopause 13:482-488.
17. Flaws JA, Doerr JK, Sipes IG, Hoyer PB 1994 Destruction of preantral follicles in adult rats by 4-vinyl-1-cyclohexene diepoxide. Reprod Toxicol 8:509-514.
18. Kao SW, Sipes IG, Hoyer PB 1999 Early effects of ovotoxicity induced by 4-vinylcyclohexene diepoxide in rats and mice. Reprod Toxicol 13:67-75.
19. Springer LN, McAsey ME, Flaws JA, Tilly JL, Sipes IG, Hoyer PB 1996 Involvement of apoptosis in 4-vinylcyclohexene-diepoxide induced ovotoxicity in rats. Toxicol Appl Pharmacol 139:394-401.
20. Springer LN, Tilly JL, Sipes IG, Hoyer PB 1996 Enhanced expression of bax in small pre-antral follicles during 4-vinylcyclohexene diepoxide induced ovotoxicity in rats. Toxicol Appl Pharmacol 139:402-410.
21. Hu X, Christian P, Sipes IG, Hoyer PB 2001 Expression and redistribution of cellular Bad, Bax, and Bcl-X(L) protein is associated with VCD-induced ovotoxicity in rats. Biol Reprod 65:1489-1495.
22. Hu X, Christian PJ, Thompson KE, Sipes IG, Hoyer PB 2001 Apoptosis induced in rats by 4-vinylcyclohexene diepoxide is associated with activation of the caspase cascades. Biol Reprod 65:87-93.
23. Hu X, Flaws JA, Sipes IG, Hoyer PB 2002 Activation of mitogen-activated protein kinases and AP-1 transcription factor in ovotoxicity induced by 4-vinylcyclohexene diepoxide in rats. Biol Reprod 67:718-724.
24. National Toxicology Progam 1989 Toxicology and Carcinogenesis Studies of 4-Vinyl-1-Cyclohexane Diepoxide in F344/N Rats and B6C3F1 Mice. U.S. Department of Health and Human Services, Research Triangle Park, NC, USA.
25. Bouxsein ML, Glatt VG, Canalis E, Stadmeyer L 2007 Age-related changes in trabecular architecture differ in female and male C57B1/6J mice. J Bone Miner Res 22:1197-1207.
26. Meinel L, Fajardo R, Hofmann S, Langer R, Chen J, Snyder B, Vunjak-Novakovic G, Kaplan D 2005 Silk implants for the healing of critical size bone defects. Bone 37:688-698.
27. Ridler T, Calvard S 1978 Picture thresholding using an iterative selection method. IEEE Trans Syst Man Cybern SMC8:630-632.
28. Hildebrand T, Laib A, Muller R, Dequeker J, Ruegsegger P 1999 Direct three-dimensional morphometric analysis of human cancellous bone: Microstructural data from spine, femur, iliac crest, and calcaneus. J Bone Miner Res 14:1167-1174.
29. Hildebrand TPR 1997 A new method for the model independent assessment of thickness in three-dimensional images. J Microsc 185:67-75.
30. Laib A, Hildebrand T, Hauselmann HJ, Ruegsegger P 1997 Ridge number density: A new parameter for in vivo bone structure analysis. Bone 21:541-546.
31. Cooper C 2005 Epidemiology of osteoporosis. In: Favus MJ (ed.) Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 5th ed. Lippincott, Williams & Wilkins, New York, NY, USA, pp. 307-313.
32. Gallagher JC 2005 Effect of estrogen on bone. In: Favus MJ (ed.) Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 5th ed. Lippincott, Williams & Wilkins, New York, NY, USA, pp. 327-330.
33. Erickson GF, Magoffin DA, Dyer CA, Hofeditz C 1985 The ovarian androgen producing cells: A review of structure/function relationships. Endocr Rev 6:371-399.
34. Vanderschueren D, Vandenput L, Boonen S, Lindberg M, Bouillon R, Ohlsson C 2003 Androgens and Bone. Endocr Rev 25:389-425.
35. Lea CK, Flanagan AM 1998 Physiological plasma levels of androgens reduce bone loss in the ovariectomized rat. Am J Physiol Endocrinol Metab 274:328-335.
36. Fogle RH, Stancszyk FZ, Zhang X, Paulson R 2007 Ovarian androgen production in the postmenopausal ovary. J Clin Endocrinol Metab 10:1210.
37. Halloran BP, Furguson VL, Simske SJ, Burghardt A, Venton LL, Majumdar S 2002 Changes in bone structure and mass with advancing age in the male C57BL/6J mouse. J Bone Miner Res 17:1044-1050.
38. Sun L, Peng Y, Sharrow AC, Iqbal J, Zhang Z, Papachristou DJ, Zaidi S, Zhu LL, Yaroslavskiy BB, Zhou H, Zallone A, Sairam MR, Kumar TR, Bo W, Braun J, Cardoso-Landa L, Schaffler MB, Moonga BS, Blair HC, Zaidi M 2006 FSH directly regulates bone mass. Cell 125:247-260.
39. Bouxsein ML, Christian PJ, Glatt V, Rosen CJ, Hoyer PB. 2005 An ovary-intact mouse model to study bone loss induced by estrogen deficiency. 2nd Joint Meeting, European Calcified Tissue Society and the International Bone and Mineral Society, June 25-29, 2005, Geneva, Switzerland.
40. Samuels A, Perry MJ, Tobias JH 1999 High-dose estrogen-induced osteogenesis in the mouse is partially suppressed by indomethacin. Bone 25:675-680.
41. Samuels A, Perry MJ, Tobias JH 1999 High-dose estrogen induces de novo medullary bone formation in female mice. J Bone Miner Res 14:178-186.
42. Samuels A, Perry MJ, Goodship AE, Fraser WD, Tobias JH 2000 Is high-dose estrogen-induced osteogenesis in the mouse mediated by an estrogen receptor? Bone 27:41-46.
43. Samuels A, Perry MJ, Gibson R, Tobias JH 2001 Effects of combination therapy with PTH and 17beta-estradiol on long bones of female mice. Calcif Tissue Int 69:164-170.
44. Plant A, Samuels A, Perry MJ, Colley S, Gibson R, Tobias JH 2002 Estrogen-induced osteogenesis in mice is associated with the appearance of Cbfa1-expressing bone marrow cells. J Cell Biochem 84:285-294.
45. McDougall KE, Perry MJ, Gibson RL, Bright JM, Colley SM, Hodgin JB, Smithies O, Tobias JH 2002 Estrogen-induced osteogenesis in intact female mice lacking ERbeta. Am J Physiol Endocrinol Metab 283:E817-E823.